Lucas Kosobuski
Overview
Explore the profile of Lucas Kosobuski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kosobuski L, Lee J, Westberg S, Chen N, Le S, Van Loon A, et al.
Innov Pharm
. 2023 Nov;
14(2).
PMID: 38025172
Human trafficking is a critical public health threat in the United States, yet education on human trafficking for pharmacy students has not been evaluated despite pharmacists being the most accessible...
2.
Treatment Court Family Nights: An Accessible and Adaptable Support for Families Engaging in Recovery
Palombi L, Van Deelen A, Hawn A, Kosobuski L, Jo Katras M
Subst Abuse
. 2023 Apr;
17:11782218231170857.
PMID: 37113269
Introduction: While public health measures including physical distancing and stay-at-home orders have clear benefits in COVID-19 mitigation and prevention, they have provided unique challenges for individuals with substance use disorder...
3.
Kosobuski L, ODonnell C, Koh-Knox Sharp C, Chen N, Palombi L
Subst Abuse Rehabil
. 2023 Jan;
13:127-138.
PMID: 36597518
Introduction: The opioid overdose crisis has claimed hundreds of thousands of lives in the United States in the last decade, with overdose numbers continuing to climb. At the same time,...
4.
Walls M, Hautala D, Cole A, Kosobuski L, Weiss N, Hill K, et al.
BMC Public Health
. 2022 May;
22(1):1002.
PMID: 35585536
Background: Research on associations between social integration and wellbeing holds promise to inform policy and practice targets for health promotion. Yet, studies of social connection too frequently rely on overly...
5.
Kosobuski L, Hawn A, France K, Chen N, LaPlante C, Palombi L
J Am Pharm Assoc (2003)
. 2022 Apr;
62(5):1555-1563.e2.
PMID: 35428578
Background: The coronavirus disease 2019 (COVID-19) pandemic has had a disproportionately negative impact on individuals with a substance use disorder (SUD). A rapidly changing public health and treatment environment has...